Novo Nordisk’s market valuation has increased so rapidly in recent weeks that it has overtaken Elon Musk’s EV giant.
Novo Nordisk On Top
A new weight loss pill being trialed by Olympic maker Novo Nordisk has sent the company’s value soaring. Its market value has now eclipsed that of electric vehicle manufacturer Tesla.
Increases to $610 Billion
On Thursday, shares in the Danish pharmaceutical company jumped over 8%, and its market capitalization hit almost $610 billion.
12th Most Valuable Company
This unprecedented surge has placed Novo Nordisk as the world’s 12th most valuable company, jumping over both Tesla and Visa, thanks to a new drug trial.
A Double-Powered Pill
The trial was of a new weight loss oral drug called amyretin, which is said to be twice as effective as their weight loss pill Wegovy.
Promising Trials
During the trial, participants lost 13% of their body weight in just 12 weeks, compared to similar trials where patients taking Wegovy lost 6% in the same period.
Investor Excitement
While the drug trials for amyretin are still ongoing, the news of its effectiveness so far has sent investors lunging for shares in the company since its value is unlikely to drop if the eventual product lives up to expectations.
A Shift in the Market
Its overtake of Tesla indicates a dramatic shift in market interests since Tesla’s market cap was four times higher than Novo Nordisk’s just two years ago at the end of 2021.
Crazy for Weight Loss Pills
According to Savita Subramanian, a top strategist for Bank of America, the market sentiment is “euphoric” over pharmaceuticals, specifically weight loss drugs, artificial intelligence, and “not much else.”
The Industry Excels
It is a huge boost for the weight loss industry across the board. While Novo shares have increased by 80% in the last 12 months, shares in its main competitor, Eli Lilly, have also gained significant value over the same period.
Not So Promising for Tesla
On the other hand, the same can’t be said for EV manufacturers like Tesla. Demand for EVs has slowed, and Tesla’s shares have risen by less than 1%.
China in the Race
Elon Musk’s company is now also in fierce competition with Chinese manufacturers – China’s BYD overtook Tesla as the world’s largest EV manufacturer in late 2023.
The Next Big Thing
Amyretin is the next in a line of phenomenally popular weight loss medications, known as GLP-1 agonists, from Novo Nordisk.
Ozempic and Wegovy
The two best-known of these products are Ozempic and Wegovy. While both contain the key ingredient semaglutide and both have gained attention as weight loss drugs, there are some differences.
Diabetes and Weight Loss
The FDA has only approved Ozempic as a treatment for Type 2 diabetes. Meanwhile, Wegovy, which has a higher dose of semaglutide, has been approved for prescription as a weight loss treatment.
Pharmaceutical Giant
Over the last few years, Novo Nordisk has cemented itself as a leader in the pharmaceutical industry, creating a new generation of weight loss medications that are helping millions of Americans fight against obesity and diabetes.
Miracle for Denmark
It has also been a miracle worker for its home country of Denmark. The company’s value now exceeds Denmark’s annual output, and it even saved the country’s economy from a recession last year.
LMVH Falls Behind
Last year, it also outperformed luxury brand conglomerate LMVH to become the most valuable listed company in Europe.
Deciding Factor for the Danish Economy
According to Jens Naervig Pedersen, a senior analyst at Danish banking multinational Danske Bank, in 2023, Novo Nordisk was the “difference between whether or not the Danish economy grew.”
Economic Firestarter
“We have this very large successful company that is pushing the economy higher,” Pederson said. “It’s creating jobs, it’s creating investments in new factories, jobs in the construction sector.”
Billions Invested
Novo Nordisk’s runaway success has given them plenty to work with. The company has announced an $8.7 billion investment package to expand its manufacturing capacity.
It also spent $11 billion in February to purchase three new factories.
21 States Where Squatters Can Legally Claim Your Property
Discover how squatters’ rights, or adverse possession, are more than just legal jargon—they’re stories of unexpected twists in the world of real estate. From sunny California to the historical landscapes of Pennsylvania, here’s how these laws could turn the tables on homeowners and squatters alike. 21 States Where Squatters Can Legally Claim Your Property
14 Things That Are Banned in the U.S. but Totally Fine Elsewhere
Ever feel like America’s rulebook was written by someone with a dartboard? Across the pond or down under, things get even wackier. Let’s take a walk on the wild side of global “Do’s” that are definite “Don’ts” in the Land of the Free. 14 Things That Are Banned in the U.S. but Totally Fine Elsewhere
25 American States Nobody Wants to Visit Anymore
Across the United States, some states capture the hearts and itineraries of many, while others remain quietly on the sidelines, overshadowed or misunderstood. These 25 states, facing what you might call a popularity crisis, are brimming with hidden wonders, cultural riches, and natural beauty, awaiting those willing to look beyond the usual tourist trails. 25 American States Nobody Wants to Visit Anymore
20 Foods That Are Cheaper to Eat Out Than Making at Home
In a world where convenience often wins, certain culinary delights come with a lower price tag when enjoyed at a restaurant rather than crafted in your own kitchen. Here are twenty foods that might save you both time and money when indulged in at your favorite eatery. 20 Foods That Are Cheaper to Eat out Than Making at Home
17 Things You’re Paying For, but You Don’t Have To
In the land of the free, there’s a price tag on everything, but savvy Americans know better than to open their wallets for just anything. Here are 17 expenses you’ve been shelling out for without realizing there’s a cheaper or even free alternative. 17 Things You’re Paying For, but You Don’t Have To
The post Weight Loss Pill Sensation Propels Pharma Giant Ahead of Tesla first appeared on From Frugal to Free.
Featured Image Credit: Shutterstock / Stock-Asso.
The content of this article is for informational purposes only and does not constitute or replace professional financial advice.
